Researching: Pfizer

Pfizer drug acquired in Seagen deal disappoints in lung cancer study

Pfizer hunts for new CFO as Denton prepares to hang up gloves, wave goodbye to pharma

Will obesity drugs save Pfizer from its post-COVID slump?

Abivax’s Phase 3 Triumph Turns Risk Event as Cancer Cases Emerge

Pfizer pens $10B, 12-drug deal with Innovent in broad bet on Chinese cancer med innovation

Race intensifies to lead next wave of obesity drugs as trial results loom

AstraZeneca’s Imfinzi Gains Ground in Bladder Cancer as Volga Trial Delivers

BridgeBio’s Attruby challenges Pfizer’s Vyndamax legacy in pivotal ATTR trial

FDA hands Pfizer, Arvinas’ Veppanu early approval for breast cancer subtype

Arvinas’ ‘Protac’ breast cancer drug cleared by FDA